Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00095654
Status:
COMPLETED
Last Update Posted:
2009-11-10
First Post:
2004-11-05
Brief Title:
The DREAM Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication Trial
Sponsor:
Gerstein Hertzel MD
Organization:
Gerstein Hertzel MD
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Glucose Metabolism Disorders |
| Impaired Glucose Tolerance |
| Cardiovascular Disease |